GlassScriptPhysician profile
William Byron Reichert
NPI 1417343369
$29,180.26
in general payments reported to CMS, 2019-2025
34 companies · $3,008 in 2025
The $3,008 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,312 · 2022: $14K · 2023: $1,786 · 2024: $2,923 · 2025: $3,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,091 · Consulting Fee: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,091.25 |
| Consulting Fee | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,327.45 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $5,741.22 | 2021-2025 | General - Therapies |
| Biosense Webster, INC. | $2,688.42 | 2022-2025 | Carto 3, Octaray Mapping Catheter |
| Abbott Laboratories | $1,493.84 | 2023-2025 | Ensite Precision, Aveir, Ensite |
| Atricure, INC. | $791.56 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $325.60 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $314.66 | 2023-2025 | |
| Edwards Lifesciences Corporation | $212.54 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Elutia, INC. | $175.00 | 2025 | Ecm Patch,Pouch |
| Amgen INC. | $172.47 | 2021-2024 | Repatha |
| Globus Medical, INC. | $152.37 | 2025 | Senza |
| Impulse Dynamics (USA) INC. | $120.04 | 2023 | Optimizer |
| Cmp Pharma, INC. | $72.11 | 2023-2025 | Atorvaliq, Liqrev, Tadliq |
| Esperion Therapeutics, INC. | $66.67 | 2024-2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $50.63 | 2023-2025 | Assure Wcd |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $45.03 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $39.24 | 2024 | Arcalyst |
| Pfizer INC. | $31.26 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $30.50 | 2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.42 | 2024 | Jardiance |
| Abiomed | $29.32 | 2025 | |
| Altathera Pharmaceuticals LLC | $28.22 | 2025 | Sotalol Hydrochloride |
| Daiichi Sankyo INC. | $27.66 | 2023 | Injectafer |
| Cardiva Medical, INC. | $25.78 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Inspire Medical Systems, INC. | $23.25 | 2025 | Inspire |
| Novo Nordisk INC | $22.28 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $21.64 | 2025 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $20.46 | 2023 | Xarelto |
| Getinge USA Sales, LLC | $20.33 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.29 | 2024 | Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $17.20 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $15.60 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.35 | 2024 | |
| Itamar Medical INC | $13.85 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Reichert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.